tiprankstipranks
Trending News
More News >
Medivir (SE:MVIR)
:MVIR
Sweden Market
Advertisement

Medivir AB (MVIR) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

MVIR Financial Forecast

MVIR Earnings Forecast

Next quarter’s earnings estimate for MVIR is -kr0.12 with a range of -kr0.12 to -kr0.12. The previous quarter’s EPS was -kr0.12. MVIR beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.13% of the time in the same period. In the last calendar year MVIR has Outperformed its overall industry.
Next quarter’s earnings estimate for MVIR is -kr0.12 with a range of -kr0.12 to -kr0.12. The previous quarter’s EPS was -kr0.12. MVIR beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.13% of the time in the same period. In the last calendar year MVIR has Outperformed its overall industry.

MVIR Sales Forecast

Next quarter’s sales forecast for MVIR is kr800.00K with a range of kr800.00K to kr800.00K. The previous quarter’s sales results were kr600.00K. MVIR beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year MVIR has Outperformed its overall industry.
Next quarter’s sales forecast for MVIR is kr800.00K with a range of kr800.00K to kr800.00K. The previous quarter’s sales results were kr600.00K. MVIR beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year MVIR has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on SE:MVIR
Joseph PantginisH.C. Wainwright
H.C. Wainwright
kr54
Buy
2547.06%
Upside
Reiterated
04/29/25
Medivir AB (MVIR) Receives a Buy from H.C. Wainwright
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on SE:MVIR
Joseph PantginisH.C. Wainwright
H.C. Wainwright
kr54
Buy
2547.06%
Upside
Reiterated
04/29/25
Medivir AB (MVIR) Receives a Buy from H.C. Wainwright
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medivir AB

1 Month
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
-5.83%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of -5.83% per trade.
3 Months
xxx
Success Rate
1/3 ratings generated profit
33%
Average Return
-13.43%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -13.43% per trade.
1 Year
Joseph PantginisH.C. Wainwright
Not Ranked
Success Rate
1/3 ratings generated profit
33%
Average Return
-8.37%
reiterated a buy rating 3 months ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -8.37% per trade.
2 Years
xxx
Success Rate
1/3 ratings generated profit
33%
Average Return
-1.17%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -1.17% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MVIR Analyst Recommendation Trends

Rating
Aug 22
Mar 23
Dec 24
Feb 25
Apr 25
Strong Buy
2
2
3
4
4
Buy
2
2
1
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
4
4
4
In the current month, MVIR has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MVIR average Analyst price target in the past 3 months is 54.00.
Each month's total comprises the sum of three months' worth of ratings.

MVIR Stock Forecast FAQ

What is SE:MVIR’s average 12-month price target, according to analysts?
Based on analyst ratings, Medivir’s 12-month average price target is 54.00.
    What is SE:MVIR’s upside potential, based on the analysts’ average price target?
    Medivir has 2547.06% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Medivir a Buy, Sell or Hold?
          Medivir has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Medivir’s share price target?
            The average share price target for Medivir is 54.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is kr54.00 ,and the lowest forecast is kr54.00. The average share price target represents 2547.06% Increase from the current price of kr2.04.
              What do analysts say about Medivir?
              Medivir’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of Medivir?
                To buy shares of SE:MVIR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis